How Much Does Semaglutide Cost Without Insurance? (2026 Guide)

Your Self-Pay Options

Prices below are as of 2026 and change frequently — verify current pricing on the manufacturer and program websites before making any decision.

1. Brand-name at list price

Wegovy and Ozempic list prices have generally run around $1,000–$1,400 per month for the medication alone, with provider visits billed separately. Few self-pay patients pay list price, because the routes below exist.

2. Manufacturer direct self-pay program (NovoCare)

Novo Nordisk sells Wegovy directly to self-pay patients through NovoCare Pharmacy: the Wegovy pen at about $349 per month, and the Wegovy pill at roughly $149–$299 per month depending on dose. You need a prescription from your own doctor or a telehealth provider, and provider visits are separate. This is the FDA-approved product with full FDA oversight of manufacturing and labeling.

3. Insurance copay programs

If your plan covers Wegovy, the manufacturer's savings card may reduce your copay substantially. Eligibility rules and caps apply, and government-insured patients are typically excluded. Check your plan's formulary and the manufacturer's current terms.

4. Compounded semaglutide programs via telehealth

Some telehealth platforms offer compounded semaglutide prepared by licensed US compounding pharmacies pursuant to a provider's prescription. Each platform sets its own pricing. FitFlowRx publishes flat pricing of $99 per month on its semaglutide treatment page — provider consultation, medication if prescribed, and shipping included, and the same price at every dose. Medication is prescribed only if a licensed provider determines it is appropriate for you.

Compounded Is Not a Lower-Cost Substitute

This matters enough to state on its own. Compounded semaglutide is not FDA-approved: the final product does not undergo FDA review for safety, effectiveness, or manufacturing quality. It is prepared by a licensed US compounding pharmacy for an individual patient pursuant to a licensed provider's prescription. It is not a generic version of Wegovy or Ozempic, and it is not a substitute for them.

Whether a compounded medication is appropriate for you is a clinical decision a licensed provider makes based on your health history — not a cost decision. If an FDA-approved product is available and appropriate for you, your provider may recommend it. Our compounded semaglutide vs Wegovy guide covers the differences in detail.

Paying With Pre-Tax Dollars (FSA/HSA)

Prescription weight loss treatment ordered by a licensed provider is generally an eligible medical expense, which means Flexible Spending Account and Health Savings Account funds can usually be applied, whichever route you take. FitFlow is FSA and HSA eligible. Check with your plan administrator for your specific plan's rules.

What Transparent Pricing Looks Like

• Pricing published on the website — before you enter payment details
• A clear statement of what the price includes (consultation, medication if prescribed, shipping)
• A real consultation reviewed by a licensed provider (at FitFlow, providers of the Wasef Health medical group)
• Medication dispensed by a licensed US pharmacy, only if prescribed
• A plain statement of whether the medication is FDA-approved or compounded

If a website sells GLP-1 medication with no provider review at all, a low price is not a bargain — it is a warning sign.

This article is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any weight loss medication. Brand-name prices are drawn from public manufacturer pricing as of 2026 and change frequently. FitFlow is a telehealth platform and does not manufacture or compound medications. Compounded medications are prepared and dispensed by licensed U.S. compounding pharmacies pursuant to a prescription from a licensed provider; compounded drugs are not FDA-approved and are not a generic version of or substitute for any FDA-approved drug. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. FitFlowRx is not affiliated with Novo Nordisk.